Grufity logoGrufity logo

STAA

60.27USD-2.06(-3.30%)Market Closed

STAAR Surgical Co

Market Summary

USD60.27-2.06Market Closed
-3.30%

STAA Alerts

STAA Stock Price

RSI Chart

Valuation

Market Cap

3.4B

Price/Earnings

101.81

Price/Sales

13.07

Price/Cashflow

86.66

MarketCap/EBT

82.69

Price/Sales

Profitability

EBT Margin

15.80%

Return on Equity

11.22%

Return on Assets

8.93%

Fundamentals

Revenue

Revenue (TTM)

279.3M

Revenue Y/Y

30.32%

Revenue Q/Q

-6.23%

Earnings

Earnings (TTM)

37.8M

Earnings Y/Y

70.47%

Earnings Q/Q

-21.29%

Price Action

52 Week Range

112.27
(Low)(High)

Last 7 days

9.0%

Last 30 days

-0.9%

Last 90 days

-36.1%

Trailing 12 Months

-34.1%

Financial Health

Current Ratio

6.37

Investor Care

Shares Dilution (1Y)

1.27%

Diluted EPS (TTM)

0.76

Peers (Alternatives to STAAR Surgical)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
10.2T
429.9M
-15.19% 31.17%
185.5K
28.0K
144.70% 331.94%
183.3B
31.3B
7.44% -13.32%
27.1
5.87
11.35% 14.95%
115.4B
30.8B
-8.94% -28.67%
22.17
3.71
-3.11% -8.14%
86.7B
17.9B
11.64% -6.61%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
11.18% -17.75%
62.6
14.1
11.47% -18.42%
13.6B
2.9B
15.70% -21.71%
31.56
4.32
18.27% -85.23%
MID-CAP
6.7B
998.4M
9.55% 2.62%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
33.31% -13.25%
-331.15
7.96
20.10% -221.96%
3.9B
380.1M
-6.98% -2.00%
-29.57
10.69
18.85% -63.58%
3.4B
279.3M
-0.95% -34.12%
101.81
13.07
28.45% 65.13%
SMALL-CAP
1.6B
126.8M
23.76% 23.16%
-26.38
14.01
34.44% -10.05%
1.0B
795.9M
15.03% -14.89%
-131.34
1.33
8.11% 182.50%
994.0M
154.8M
3.15% -46.03%
-10.57
6.72
60.29% -2309.58%
606.7M
236.2M
-5.60% -30.91%
-16.43
2.57
-8.79% -175.19%

Financials for STAAR Surgical

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue6.8%279262243230217
Gross Profit7.5%219203189179168
  S&GA Expenses5.8%168159151145138
  R&D Expenses4.0%3534343434
Earnings Before Taxes12.6%4741373129
Net Income12.6%3834292523
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets5.0%395376351346325
  Current Assets0.2%297296274271264
    Cash Equivalents-36.2%129202193200196
  Net PPE12.2%4843403632
  Goodwill0%22222
Liabilities-2.8%7577758775
  Current Liabilities-2.6%4547414947
Shareholder's Equity7.0%320299276259249
  Retained Earnings11.6%-78.49-88.75-101.79-111.39-116.31
  Additional Paid-In Capital2.9%398387379374369
Accumulated Depreciation2.6%3736353434
Shares Outstanding0.4%4848484848
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations4.5%4139334455
  Share Based Compensation12.2%1917151514
Cashflow From Investing-625.0%-114.35-15.77-14.02-13.64-11.10
Cashflow From Financing11.6%87131825

Risks

What is the probability of a big loss on STAA?

83.8%


Probability that STAAR Surgical stock will be more than 20% underwater in next one year

79.2%


Probability that STAAR Surgical stock will be more than 30% underwater in next one year.

45%


Probability that STAAR Surgical stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does STAA drawdown profile look like?

Y-axis is the maximum loss one would have experienced if STAAR Surgical was unfortunately bought at previous high price.

Returns

Cumulative Returns on STAA

27.0%


10-Year Cumulative Returns

33.2%


7-Year Cumulative Returns

29.0%


5-Year Cumulative Returns

17.3%


3-Year Cumulative Returns

What are the long-term rolling returns for STAA?

FIve years rolling returns for STAAR Surgical.

Which funds bought or sold STAA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
508,000
508,000
0.01%
2022-11-21
Parallax Volatility Advisers, L.P.
NEW
-
4,000
4,000
-%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
-104,000
3,803,000
0.01%
2022-11-17
CENTRAL TRUST Co
SOLD OFF
-100
-
-
-%
2022-11-16
Retirement Systems of Alabama
REDUCED
-0.15
-30,000
4,437,000
0.02%
2022-11-16
GLENMEDE TRUST CO NA
NEW
-
247,000
247,000
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-12,000
-
-%
2022-11-15
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
UNCHANGED
-
-2,000
395,000
-%
2022-11-15
PITTENGER & ANDERSON INC
ADDED
37.14
2,000
7,000
-%
2022-11-15
JANE STREET GROUP, LLC
ADDED
28.72
555,000
2,534,000
-%

1–10 of 43

Latest Funds Activity

Are funds buying STAA calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own STAA

STAAR Surgical News

MarketBeat

STAAR Surgical (NASDAQ:STAA) Short Interest Down 22.8% in November.5 days ago

STAA Fair Value

Recent SEC filings of STAAR Surgical

View All Filings
Date Filed Form Type Document
Nov 03, 2022
8-K
Current Report
Nov 02, 2022
8-K
Current Report
Nov 02, 2022
10-Q
Quarterly Report
Sep 29, 2022
4
Insider Trading

Latest Insider Trading transactions for STAA

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-09-27
Francese James E
ACQUIRED
98,324
7.52
13,075
Sr. VP, Comm. Ops., NA, APAC
2022-09-27
Francese James E
SOLD
-2,656,880
75
-35,425
Sr. VP, Comm. Ops., NA, APAC
2022-08-15
Holliday Keith
SOLD
-1,762,500
106.29
-16,582
Chief Technology Officer
2022-08-15
Holliday Keith
ACQUIRED
393,675
33.9902
11,582
Chief Technology Officer
2022-06-16
Yu K Peony
ACQUIRED
-
-
355
-
2022-06-16
Lin Elizabeth Yeu
ACQUIRED
-
-
355
-
2022-06-16
Kliman Gilbert H
ACQUIRED
-
-
3,254
-
2022-06-16
FRINZI THOMAS G
ACQUIRED
-
-
1,805
-
2022-06-16
FARRELL STEPHEN C
ACQUIRED
-
-
355
-
2022-06-07
Williams Patrick F.
ACQUIRED
-
-
5,121
Chief Financial Officer

1–10 of 50

Caren L. Mason
810
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAA Income Statement

2022-09-30
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Income Statement [Abstract]    
Net sales$ 76,046$ 58,352$ 220,347$ 171,471
Cost of sales15,58413,05146,74937,825
Gross profit60,46245,301173,598133,646
Selling, general and administrative expenses:    
General and administrative14,01111,01839,93432,671
Selling and marketing23,13018,17564,63350,229
Research and development9,6168,27126,19324,790
Total selling, general and administrative expenses46,75737,464130,760107,690
Operating income13,7057,83742,83825,956
Other expense, net:    
Interest income (expense), net897(23)934(35)
Loss on foreign currency transactions(2,129)(610)(4,904)(2,040)
Royalty income77185527496
Other income (expense), net27(13)178(47)
Total other expense, net(1,128)(461)(3,265)(1,626)
Income before income taxes12,5777,37639,57324,330
Provision for income taxes2,3151,3566,6714,751
Net income$ 10,262$ 6,020$ 32,902$ 19,579
Net income per share:    
Basic$ 0.21$ 0.13$ 0.69$ 0.42
Diluted$ 0.21$ 0.12$ 0.67$ 0.40
Weighted average shares outstanding:    
Basic48,10247,48347,91547,064
Diluted49,54949,59249,37149,448

STAA Balance Sheet

2022-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 129,242$ 199,706
Investments available for sale82,091 
Accounts receivable trade, net of allowance for credit losses of $103 and $43, respectively55,42943,531
Inventories, net19,93017,274
Prepayments, deposits and other current assets10,21810,900
Total current assets296,910271,411
Investments available for sale13,360 
Property, plant and equipment, net48,04835,912
Finance lease right-of-use assets, net380506
Operating lease right-of-use assets, net29,50331,310
Intangible assets, net171218
Goodwill1,7861,786
Deferred income taxes3,7103,813
Other assets808822
Total assets394,676345,778
Current liabilities:  
Accounts payable7,5678,699
Obligations under finance leases167127
Obligations under operating leases3,4743,283
Allowance for sales returns5,0404,816
Other current liabilities29,07231,877
Total current liabilities45,32048,802
Obligations under finance leases252382
Obligations under operating leases26,03228,269
Deferred income taxes1,554811
Asset retirement obligations158198
Pension liability1,2288,758
Total liabilities74,54487,220
Commitments and contingencies
Stockholders’ equity:  
Common stock, $0.01 par value; 60,000 shares authorized: 48,202 and 47,716 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively482477
Additional paid-in capital398,448373,519
Accumulated other comprehensive loss(310)(4,048)
Accumulated deficit(78,488)(111,390)
Total stockholders’ equity320,132258,558
Total liabilities and stockholders’ equity$ 394,676$ 345,778